Intercept raises $30M in series C

Intercept Pharmaceuticals Inc. (New York, N.Y.) raised $30 million in a series C round led by OrbiMed Advisors. Existing investor Genextra S.p.A. (Milan, Italy) participated. Intercept's obeticholic a...